TAM
IMVT icon

TFG Asset Management’s Immunovant IMVT Stock Holding History

TFG Asset Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.86M Buy
255,934
+37,427
+17% +$1.14M 1.55% 15
2026
Q1 		$5.43M Buy
218,507
+52,320
+31% +$1.35M 1.05% 16
2025
Q4 		$4.22M Sell
166,187
-22,192
-12% -$495K 0.89% 17
2025
Q3 		$3.04M Buy
188,379
+40,562
+27% +$657K 0.41% 25
2025
Q2 		$2.37M Buy
147,817
+16,650
+13% +$252K 0.38% 25
2025
Q1 		$2.24M Buy
+131,167
New +$2.74M 0.51% 19

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TFG Asset Management's IMVT Position: Q2 2026 in Review

TFG Asset Management increased its Immunovant (IMVT) stake by 17% in Q2 2026, buying an estimated $1.14M and bringing the position to 255,934 shares worth $9.86M. The position accounts for 1.55% of the portfolio, ranked #15.

TFG Asset Management first reported a position in IMVT in Q1 2025 and has held it in 6 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • TFG Asset Management held 255,934 shares of Immunovant worth $9.86M as of Q2 2026.
  • TFG Asset Management bought 37,427 Immunovant shares in Q2 2026, an estimated $1.14M.
  • Immunovant made up 1.55% of TFG Asset Management's portfolio in Q2 2026, its #15 holding.
  • TFG Asset Management first reported a position in Immunovant in Q1 2025 and has held it in 6 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on TFG Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.